Drugs Medical Pharma

Novartis sells eye business to Bausch+Lomb for $2.5 billion

HQ Team July 3, 2023: Swiss drugmaker Novartis is divesting its ophthalmology assets including Xiidra, an anti-inflammatory eye drop to Bausch + Lomb,.

Read More
Climate Health Pharma

Scientists hunt ways to unearth hidden structures in 99% of world’s chemical compounds 

HQ Team July 2, 2023: Biological or chemical threats may be lurking in the universe’s chemical world, or cures for disease and tackling.

Read More
Climate Health Pharma

Airseas, green kite maker towing cargo ships, to open factory as demand surges 

HQ Team July 1, 2023: Airseas, a French company that makes automated kites to channel wind power to tow cargo ships, plans to.

Read More
Drugs Health Pharma

Human embryo model to predict early stage pregnancy failure

Researchers at the University of Cambridge have moved away from cells of zebrafish and mice to create a “human embryo-like model” from human.

Read More
Drugs Health Pharma

Artificial sweetener sucralose breaks up DNA, may cause ‘leaky gut’

HQ Team June 30, 2023: Artificial sweetener, sucralose, is “genotoxic” as it breaks up the DNA and causes damage to the gut lining.

Read More
Drugs Medical Pharma

Wellcome, Bill & Melinda invest $550 million for new TB vaccine

HQ Team June 30, 2023: Two philanthropic health majors, Wellcome and the Bill & Melinda Gates Foundation, have come together to invest around.

Read More
Health Medical Pharma

Meta study finds strong link between gut microbes and autism

HQ Team June 29, 2023: Recent research has shed new light on the connection between autism spectrum disorder (ASD) and the body’s ‘second.

Read More
Climate Health Pharma

US beekeepers lose half of managed colonies, hives death rate rise

HQ Team June 28: 2023: American beekeepers lost nearly half of their managed colonies even as honeybee hives buzzed through their second-highest death.

Read More
Climate Drugs Pharma

Covid-19, summer heat, mpox challenges haunt European region

HQ Team June 28, 2023: Extreme summer heat and a resurgence of mpox in Europe are adding to the hardship created by the.

Read More
Drugs Medical Pharma

FDA, EMA accept Pfizer’s BLP application for hemophilia therapy

HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.

Read More